Background: Mast cells are versatile key components of allergy and inflammation known to respond to both innate and adaptive immunologic stimuli. However, the response of individual mast cells to cumulative stimuli remains poorly understood. Objectives: We sought to dissect mast cell responses at the single-cell level and their potentiation by IL-33. Methods: We monitored mast cell degranulation in real time by exploiting the capacity of fluorochrome-labeled avidin to stain degranulating cells. During the degranulation process, the granule matrix is externalized and immediately bound by fluorochrome-labeled avidin present in the culture medium. The degranulation process is monitored by using either time-lapse microscopy or fluorescence-activated cell sorting analysis. Results: Single-cell analysis revealed a strong heterogeneity of individual mast cell degranulation responses. We observed that the number of degranulating mast cells was graded according to the FcεRI stimulation strength, whereas the magnitude of individual mast cell degranulation remained unchanged, suggesting an all-or-none response of mast cells after FcεRI triggering. IL-33 pretreatment increased not only the number of degranulating and chemokine-producing mast cells but also the magnitude of individual mast cell degranulation and chemokine production. Conclusion: We illustrate the effect of IL-33 on mast cell biology at the single-cell level by showing that IL-33 potentiates IgEmediated mast cell responses by both increasing the number of responding cells and enhancing the responses of individual mast
Mast cells are innate immune cells hosted in all tissues and more particularly in tissues facing the environment, such as the skin and mucosa. Mast cells are not only sentinel cells capable of sensing danger signals but also effector cells in virtually all inflammatory processes. 1 They are characterized by a cytoplasm filled with storage granules (secretory lysosomes) in which several bioactive molecules are stocked. 2 This property endows mast cells with the ability to respond swiftly and efficiently by releasing their granule content in the extracellular milieu, a process called degranulation. Moreover, mast cells are able to synthetize de novo a vast array of cytokines and chemokines. 3 Mast cells respond to a large panel of stimuli and notably to adaptive immune stimuli through Fc receptors and danger signals present in the microenvironment 4 and are involved in several inflammatory and allergic processes. [5] [6] [7] On allergen contact, epithelial cells produce IL-33, IL-25, and thymic stromal lymphopoietin (TSLP). These cytokines contribute to the pathogenesis of allergic diseases by boosting the function of type 2 innate lymphoid cells, basophils, and mast cells. [8] [9] [10] The genes encoding for IL-33 and its receptor have been identified as susceptibility loci for asthma, 11 and IL-33 is implicated in several allergic processes. 12 Moreover, mast cells seem to react mainly to IL-33.
13-15 IL-33 functions as an alarmin secreted by dying or damaged cells. 16, 17 Its production is exacerbated in patients with asthma, 18 chronic obstructive lung disease, 19 or inflammatory bowel diseases. 20 On the one hand, IL-33 promotes mast cell maturation (notably by increasing the amount of prestored mediators 21, 22 ), induces cytokine production, and increases degranulation induced by IgE/antigen stimulation. [23] [24] [25] [26] On the other hand, prolonged treatment with IL-33 has been found to downregulate mast cell signaling, 27 suggesting that IL-33 exerts different effects on mast cells in chronic conditions when compared with the acute allergic phase. Moreover, stimulation of mast cells with IL-33 in the absence of IgE crosslinking can even play an anti-inflammatory role by inducing regulatory T-cell expansion, as shown in a papain-induced innate-type airway inflammation model. 28 These results show that IL-33 is a multifaceted cytokine that can play different roles in the immune response, and not all of them are presently fully characterized. In the present work, to better understand the role played by IL-33 in the early steps of mast cell activation, we analyzed in detail several mast cell responses triggered by FcεRI aggregation after pretreatment with IL-33 at the single-cell level.
Abbreviations used
Pioneering studies that investigated the effect of IL-33 on mast cell degranulation and cytokine production were based on bulk assays. [23] [24] [25] [26] Indeed, mast cell degranulation is usually assessed by measuring the amount of released granule molecules in the cell supernatant, such as b-hexosaminidase, tryptase, or histamine. These assays do not take into account the heterogeneity of the single-cell responses. Accordingly, several lines of evidence indicate that population data do not faithfully reflect how single cells respond to stimuli. 29 Indeed, bulk assays can provide similar results for stimulated populations exhibiting either a high frequency of low-responder cells or a low frequency of high-responder cells. Nevertheless, the presence of low-or high-responder cells might have utterly different outcomes in pathophysiologic settings. Single-cell analysis of degranulation was addressed more than 30 years ago in mast cells and basophils by measuring cellular parameters associated with the degranulation process using flow cytometry. [30] [31] [32] [33] [34] [35] These studies pointed out the importance of single-cell analysis by showing heterogeneity in cellular responses and by outlining that different cell behaviors could be observed depending on the stimulus or the cell type. Nevertheless, the methods used thus far measured basophil or mast cell responses across the degranulation process, such as F-actin polymerization, CD11b expression, CD63 exposure, or forward scatter changes, but did not measure directly the terminal step of the process (ie, granule exteriorization). In addition, these measurements did not always reflect the amount of mediators released on degranulation. 34 To go further, we set up a method that allows us to measure the final step of degranulation in individual mast cells. This method allows us to monitor degranulation by using microscopy or flow cytometry at the single-cell level and relies on the mast cell granule matrix properties. Mast cell granules contain a serglycin proteoglycan matrix in which several mast cell mediators are embedded. 36 Serglycin is made of a protein core to which sulfated and thereby negatively charged glycosaminoglycan, such as heparin/heparin sulfate or chondroitin sulfate, are linked. Avidin was shown to selectively bind to heparin glycosaminoglycan 37 and to bind highly preferentially to mast cell granules rather than to other cellular structure. In human subjects and rodents avidin conjugated to fluorochrome was shown to selectively stain mast cells in fixed preparations/tissues, 38, 39 suggesting that this non-cell-permeant dye might be used to monitor degranulation in live cells. On degranulation, the granule and plasma membrane fuses together, and the granule matrix enters into contact with the extracellular milieu and is immediately bound by the avidin probe. In a previous study this method allowed us to show that mast cells form degranulatory synapses with antibody-targeted cells. 40 In the present study we used this avidin-based method to analyze human mast cell (hMC) degranulation simultaneously with either intracellular calcium ([Ca 21 ] i ) increase or chemokine production at the single-cell level. This analysis showed a high heterogeneity of individual mast cell responses. Although only a fraction of the mast cell population degranulated in response to FcεRI triggering, responding cells exhibited different levels of degranulation. Interestingly, increasing the strength of stimulation augmented the fraction of responding cells but did not influence the mean level of individual cell responses, suggesting that FcεRI triggering induces an all-or-none degranulation response. We also monitored responses of individual mast cells to cumulative stimuli by investigating how individual mast cell responses to FcεRI aggregation were influenced by IL-33. Our results reveal that IL-33 increases the frequency of mast cells responding to FcεRI aggregation and induces cells with a high-responder phenotype by augmenting, at the single-cell level, the magnitude of degranulation and chemokine production.
METHODS

Confocal microscopic analysis of hMC degranulation
hMCs (5 3 10 4 ) previously sensitized with human IgE were plated on poly-D-lysine (Sigma, St Louis, Mo)-coated Lab-Tek chambered cover glass (Nunc; Thermo Fisher, Waltham, Mass) in Tyrode buffer supplemented with 8 mg/mL avidin-sulforhodamine 101 (Av.SRho; a highly cationic glycoprotein that selectively stains mast cell granules), annexin V-Alexa Fluor 647 (final 3% vol/vol), or FM1-43 (5 mg/mL), as indicated, and warmed at 378C for 20 minutes. Cells were stimulated with 2.5 mg/mL goat IgG antihuman IgE at time 0. Fluorescence was acquired every 2.3 seconds by using the Zeiss LSM 710 Confocal Microscope (Zeiss, Oberkochen, Germany) and ZEN software, an environmental chamber (378C and 5% CO 2 ), and a 633 Plan-Apochromat objective (1.4 oil). The same protocol was applied to 1 3 10 4 mast cells embedded in 200 mL of BD Matrigel (2.5 mg/mL in Tyrode buffer; BD Biosciences, San Jose, Calif). Z-stack images were acquired with an interval of 0.4 mm 30 minutes after stimulation. In other experiments hMCs were stimulated as above onto poly-D-lysine-coated diagnostic slides (Thermo Scientific) for 30 minutes at 378C and then fixed and stained for chymase and tryptase. The samples were mounted and examined with a Zeiss LSM 710 Confocal Microscope and ZEN software with a 633 PlanApochromat objective (1.4 oil) and electronic zoom of 3.
Image quantification
Movies were analyzed by using the Region Measurements function of Metamorph software (Universal Imaging, Downingtown, Pa). Threedimensional (3D) projection of degranulated mast cells was obtained by using the interactive 3D surface plot (Image J), and 3D reconstruction of degranulated mast cell in Matrigel was obtained with Imaris software (Bitplane; Oxford Instruments, Abingdon, United Kingdom). Colocalization analysis was performed with the Linescan function of Metamorph software (Universal Imaging).
Mast cell degranulation assays
hMCs were sensitized with 1 mg/mL human IgE overnight. For time-lapse flow cytometric analysis, 1 3 10 6 hMCs were washed and distributed in Tyrode buffer containing 5 mg/mL Av.A488. Acquisition was performed in a final volume of 1 mL at 378C. Baseline (F 0 ) was set during 3.8 minutes, and then cells were stimulated with indicated concentrations of anti-IgE antibodies for approximately 20 minutes (F) by using the time function of the LSRII Cytometer (BD Biosciences). For degranulation assays, 5 3 10 4 human IgEsensitized hMCs were distributed in 96-well flat-bottom plates at a density of 1 3 10 5 cells in 50 mL of Tyrode buffer and adapted to 378C for 20 minutes. hMCs were then stimulated with anti-IgE antibodies in 50 mL of prewarmed Tyrode buffer for 30 minutes at 378C in a 5% CO 2 atmosphere. Supernatants were harvested, and b-hexosaminidase was assayed by measuring release of p-nitrophenol from the substrate p-nitrophenyl N-acetyl-b-D-glucosaminide. The cells were next stained with 5 mg/mL Av.A488 or anti-CD63-phycoerythrin (PE) at 48C for 30 minutes and then proceeded to flow cytometric analysis (MACSQuant Analyzer 10; Miltenyi Biotec, Bergisch Gladbach, Germany). FlowJo software (TreeStar, Ashland, Ore) was used to analyze the data. In some parallel experiments hMCs were sensitized overnight with 1 mg/mL anti-dinitrophenol (DNP) IgE and stimulated with DNP-HSA.
Ca 21 measurements
IgE-sensitized hMCs were preloaded for 45 minutes with 5 mmol/L Indo-1 AM calcium probe and then washed with PBS. Cells were prewarmed at 378C in Tyrode buffer containing 5 mg/mL Av.A488, and the baseline ratio was acquired for 3. 
Data analysis
Correlations between b-hexosaminidase released and flow cytometric measurements were analyzed (10 independent experiments) by using linear or nonlinear (Hill equation, y 5 
Statistical analysis
Unpaired Student t tests or Mann-Whitney tests were used for comparing 2 groups. Av.A488 fluorescence intensities (FIs) were extracted from FlowJo software (n 5 approximately 10,000 for each condition) and plotted by using box-and-whisker plots, the Mann-Whitney test was used to compare FIs, and the Wilcoxon matched-paired test was used to compare FI medians from at A complete description of the methods used is available in the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS
Avidin binds to mast cell surfaces on degranulation
IgE-sensitized primary hMCs were stimulated with anti-IgE antibodies in the presence of avidin-sulforhodamine (Av.SRho) in incubation medium to monitor degranulation dynamics by using high-resolution time-lapse confocal microscopy. As shown in Video E1 in this article's Online Repository at www.jacionline. org and Fig 1, A, the budding granules were detected on the hMC surface after about 5 minutes of stimulation. During the degranulation process, some exocytosed granules were released in the extracellular milieu, whereas a substantial portion of the exocytosed granules was retained on the hMC surface by forming a corona. We used the Region Measurement function of the MetaMorph software to measure the integrated fluorescence intensity (IFI) of the Av.SRho staining on the hMC surface (Fig  1, B) . As shown in Fig 1, the cells analyzed exhibited different response curves, plateauing at different FIs.
To ascertain whether avidin staining revealed exteriorized granules bound on the mast cell surface, we stained for tryptase and chymase 30 minutes after stimulation. Confocal images (Fig 1, C) and FI analysis (Fig 1, D and E) showed a superimposition of the Av.SRho staining with tryptase and chymase on the cell surface. To rule out the possibility that granule remnants might stay attached on the cell surface because of culture conditions in the absence of surrounding extracellular matrix, we performed similar experiments in a surrogate extracellular matrix. 3D reconstitution of degranulated cells in Matrigel showed that, in parallel with granule release, mast cells retained on their surface exteriorized granules (Fig 1, F) .
We next compared the avidin-based method with 2 other methods previously used to monitor cell secretion: annexin V binding and FM1-43 staining. Because phosphatidylserine 1 hMCs. C, Av.A488 gMFI and b-hexosaminidase release (mean 6 SD). D and E, Correlation analysis. F and G, Av.A488 FI of the degranulated hMCs (see gate panel A) from one representative experiment (Fig 3, F) or plotted as median FI (Fig 3, G) . P values were determined by using the Mann-Whitney test: ***P < .001 and ****P < .0001. ns, P > .05. Abs, Antibodies.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 2 (Fig 4, D) , representative fluorescence-activated cell sorting profiles depicting Indo-1 ratio over time (Fig 4, E) , and relative calcium response represented as means of 3 independent experiments (Fig 4, F) are shown. Abs, Antibodies.
exposure occurs at sites of secretory granule exteriorization after FcεRI triggering, 41 annexin V has been previously used to analyze mast cell degranulation.
42 FM1-43 has been widely used to monitor exocytosis in secretory cells. 43, 44 We induced mast cell degranulation in the presence of Av.SRho, annexin V-Alexa Fluor 647, and FM1-43 (added to the incubation medium) and analyzed the fluorescence of these 3 probes by using confocal time-lapse microscopy (see Fig E1 and Video E2 in this article's Online Repository at www. jacionline.org). Recorded IFI (see Fig E1, B) showed a simultaneous increase of the Av.SRho and FM1-43 IFI, whereas annexin V-Alexa Fluor 647 IFI increase was slightly delayed. The 3 probes colocalized on the mast cell surface at the end of the recording time (see Fig E1, C and D) .
Together, the above results show that fluorochrome-labeled avidin allows us to monitor degranulation kinetics and directly visualize the degranulated material at the single-cell level by using confocal laser scanning microscopy.
Heterogeneity of hMC degranulation at the population level notwithstanding homogeneous calcium responses
We next used flow cytometry to measure the degranulation extent of individual cells at the population level by using fluorescent avidin. IgE-sensitized hMCs were incubated in Tyrode buffer containing avidin-A488 at 378C and acquired for a few minutes by using the Time function of the cytometer to set the fluorescence baseline (F 0 ; Fig 2, A and B, and see Video E3 in this article's Online Repository at www.jacionline.org). At a time of 3.8 minutes, hMCs were stimulated by adding 2.5 mg/mL antiIgE antibodies. Acquisition of cells up to a total time of 25 minutes showed that hMCs progressively stained with avidin-A488 and that fluorescence increased in some cells, whereas others remained negative (Fig 2, A and B , and see Video E3). Relative avidin-A488 fluorescence F/F 0 of the whole population showed a rapid increase that reached a plateau within approximately 5 minutes after stimulation (Fig 2, C) , indicating that the mast cell surface covering with granule remnants (ie, corona formation) reached its maximum within 5 minutes.
Also, it is noteworthy that the maximum b-hexosaminidase release in the medium (a gold standard method to detect degranulation) was reached 5 minutes after stimulation with 2.5 mg/mL anti-IgE antibodies (see Fig E2 in this article' s Online Repository at www.jacionline.org). Nevertheless, b-hexosaminidase release is a bulk assay that does not illustrate the behavior of individual cells. Conversely, the avidin-binding assay allowed single-cell analysis and revealed the behavior of individual cell responses. If all the hMCs would degranulate to the same extent, the avidin-A488 FIs would distribute in a Gaussian manner at the end of the degranulation process. In opposition, our analysis showed that after plateauing, the hMC avidin FI profiles of the avidin-positive hMC population (analyzed 8, 12, 16, and 20 minutes after stimulation; see gates in Fig 2, B) did not P values were determined by using the paired t test. C and D, Av.A488 FI of the degranulated hMCs from 1 representative experiment (Fig 5, C) or plotted as median FI (mean 6 SEM; Fig 5, D) . P values were determined by using the Mann-Whitney test (Fig 5, C) or Wilcoxon test (Fig 5, D) . Abs, Antibodies. ns, P > .05. *P < .05, **P < .01, ***P < .001, and ****P < .0001.
exhibit a Gaussian distribution and remained stable during this time (Fig 2, D) .
To further evaluate the hMC response heterogeneity, we performed similar experiments with another stimulation system: anti-DNP IgE/DNP-HSA. We observed a non-Gaussian distribution of the degranulated hMCs (see Fig E3, A and B, in this article's Online Repository at www.jacionline.org). This non-Gaussian distribution was also observed with suboptimal or supraoptimal stimuli. To rule out the possibility that the heterogeneity we observed might be due to in vitro expansion of hMCs, we also investigated the degranulation distribution profile of ex vivo mouse peritoneal mast cells using the mouse anti-DNP IgE/DNP-HSA as a stimulation system. We made conspicuous a strong heterogeneity of the degranulation magnitudes (see Fig E4, A and B, in this article's Online Repository at www.jacionline.org). Taken together, these results show heterogeneity of hMC degranulation responses at the single-cell level, with cells exhibiting a responder profile ranging from very low to high.
Because [Ca 21 ] i increase is a key event in granule exocytosis, we analyzed both calcium responses and mast cell degranulation after FcεRI triggering using time-lapse flow cytometry. Mast cells were preloaded with the ratiometric calcium probe Indo-1 and incubated in Tyrode medium containing avidin-A488 at 378C. Resting cells were monitored by means of flow cytometry for 3.8 minutes (for baseline setting), and then cells were stimulated with anti-IgE antibodies and immediately analyzed by using flow cytometry for 10 minutes. [Ca 21 ] i increase in the hMC population (Fig 6, B) or CXCL8 1 (Fig 6, D) hMCs. C and E, CCL4 1 (Fig 6, C) or CXCL8 1 (Fig 6, E) hMC FI median. P values were determined by using the paired t test. Abs, Antibodies. ns, P > .05, *P < .05, **P < .01, ***P < .001, and ****P < .0001.
was proportional to the stimulus strength, and all the cells underwent comparable [Ca 21 ] i increase, whereas only a fraction of cells underwent degranulation (Fig 2, E and F , and see Video E4 in this article's Online Repository at www.jacionline.org). Interestingly, comparison of Indo-1 ratios measured 2 minutes before and 2 minutes after stimulation (see gray and red boxes in Fig 2, F) showed that the whole mast cell population underwent [Ca 21 ] i increase at any anti-IgE antibody concentration tested (Fig 2, G) . In a parallel approach we measured phosphotyrosine staining by using fluorescence-activated cell sorting analysis after stimulation with anti-IgE antibodies, a parameter associated to cell protein kinase function. 45, 46 In line with [Ca 21 ] i measurements, this approach showed that the whole mast cell population underwent dose-dependent tyrosine kinase signaling after stimulation.
These results indicate that the whole hMC population is triggered through FcεRI aggregation. Nevertheless, activation of main signaling pathways in individual cells is not always followed by degranulation.
Mast cell degranulation induced by FcεRI triggering is an all-or-none response
We next investigated whether the stimulation of mast cells with increasing concentrations of anti-IgE antibodies would result in increased degranulation at the single-cell level. Cells were analyzed 30 minutes after stimulation (when the degranulatory process is completed; Fig 2, C) by using flow cytometry and by measuring b-hexosaminidase release. The percentage of avidin-A488 1 cells and avidin-A488 geometric mean fluorescence intensity (gMFI) of the entire hMC population increased with the strength of the stimulation, similarly to the percentage of b-hexosaminidase release estimated by using the classical b-hexosaminidase assay (Fig 3, A-C) .
We next analyzed whether the avidin-based single-cell measurements reflected the extent of the degranulation, as measured by using a standard bulk assay (b-hexosaminidase release). We first determined the relationship between the percentage of degranulated cells as measured by using flow cytometry and the percentage of b-hexosaminidase release. The data were fit either to a linear function or to a Hill equation, similarly to a previous study on basophil degranulation (Fig 3, D) . 34 Linear regression showed a good fitting (0.95 < r 2 < 0.98) for all experiments analyzed, and nonlinear regression showed a good fit with Hill coefficient a very close to 1 and a very high k constant value, indicating a linear relationship. This analysis showed that although the 2 assays do not measure the same parameter of the degranulation process, the percentage of avidin-positive cells is linearly correlated with the percentage of degranulation, as measured by using a standard assay. A similar analysis indicated also that the amount of b-hexosaminidase released and the Av.A488 gMFI of the hMC population were linearly correlated (Fig 3, E) . Thus these results show that avidin-A488 gMFI is a good measurement of the degranulation extent at the population level and that the fraction of mast cells that degranulate increases with the strength of the FcεRI stimulation.
Therefore the avidin-A488-based assay allowed us to study the degranulation magnitude of individual cells within the mast cell population by analyzing the avidin-A488 FI of cells undergoing degranulation (avidin-A488 1 cells). Surprisingly, the magnitude of degranulation of avidin-positive mast cells did not increase according to the stimulus strength (Fig 3, F) . Box-and-whisker plots made conspicuous a similar repartition of avidin-A488 FI among hMCs, with no statistical differences between hMCs stimulated with low or high concentrations of anti-IgE antibodies. Moreover, analysis of the median avidin-A488 FI using hMCs from different donors showed that the median response did not change with the strength of the applied stimulus (Fig 3, G) . Additional sets of experiments were conducted by using different stimulation systems: anti-DNP IgE/DNP-HSA (to avoid a possible involving of FcgRIIB through anti-IgE antibody stimulation) and cell-bound antigens (anti-CD20 IgE/B cells 40 ). We observed that in conditions in which sensitized hMCs were stimulated with a multivalent antigen or with cell-bound antigens, degranulation occurred in an all-or-none fashion (see Fig E3, C-F) . Similar results were obtained by using ex vivo mouse peritoneal mast cells sensitized with anti-DNP IgE and stimulated with increasing concentrations of DNP-HSA (see Fig E4, C and D) , showing that this all-or-none response is not limited to primary cell lines.
Taken together, the above results show that, independent of the method used to aggregate FcεRI and the degree of FcεRI aggregation, an increased stimulation strength recruits an increased number of hMCs to degranulate without increasing the magnitude of degranulation at the single-cell level. These results imply also that FcεRI-mediated degranulation is an all-or-none response in individual mast cells.
IL-33 augments the extent of hMC degranulation without affecting calcium signaling
IL-33 is involved in allergy and has been shown to potentiate mast cell responses 47 ; nevertheless, its effect on hMC degranulation has not been thoroughly studied. We first investigated the effect of IL-33 on hMC degranulation kinetics. We performed a set of experiments similar to those described in Fig 2, A, with cells pretreated with 1 to 5 ng/mL IL-33 for 1 hour. It was important to stimulate all the cells under identical experimental conditions and at the same time to compare the degranulation kinetics of hMCs pretreated or not with IL-33. To this end, we used a barcoding method, staining each IL-33-pretreated cell with a known concentration of a fluorescent cell tracer (Fig 4, A) . Degranulation analysis at the population level showed that IL-33 potentiated in a dose-dependent manner the degranulation induced by a suboptimal concentration of anti-IgE antibodies (Fig 4, B and C, and see Video E5 in this article's Online Repository at www. jacionline.org) without changing the FcεRI expression level (see Fig E5 in this article' s Online Repository at www. jacionline.org). IL-33 did not modify the time course of degranulation that started at the same time and reached a plateau after about 5 minutes in all tested conditions. Noticeably, pretreatment with 5 ng/mL IL-33 induced a degranulation magnitude comparable with that obtained by using a high concentration of anti-IgE antibodies (compare Fig 4, C, to Fig 2, C) .
In parallel experiments we investigated whether IL-33 pretreatment might affect [Ca 21 ] i increase after FcεRI aggregation. We observed that the [Ca 21 ] i increase exhibited similar time kinetics and amplitude of responses both in untreated and IL-33-pretreated hMCs (Fig 4, D-F) .
Taken together, these results indicate that IL-33 potentiates hMC degranulation through a mechanism that does not affect calcium signaling.
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IL-33 drives individual mast cells toward a high responder phenotype
The degranulation kinetics analysis using flow cytometry showed the heterogeneity of the hMC response and suggested that IL-33 induced the emergence of cells exhibiting a high degranulation responses (Fig 4, B , and see Video E5). Thus we analyzed whether IL-33 could enhance the magnitude of degranulation by individual hMCs using the same approach used in Fig 3. As shown in Fig 5, A and B , the frequency of degranulated cells after anti-IgE antibody stimulation augmented with the concentration of IL-33 pretreatment, in particular at suboptimal concentrations of anti-IgE antibodies. IL-33 per se did not induce degranulation. Statistical analysis of the avidin staining (avidin-A488 FI) of responder cells (avidin-A488 1 ) after stimulation with a suboptimal concentration of anti-IgE antibodies showed that not only the frequency but also the magnitude of the degranulation increased according to the IL-33 concentration. Indeed, box-and-whisker plots showed that avidin-A488 median FI of individual hMCs in the responder population increased according to the concentration of IL-33 (Fig 5, C) . Moreover, analysis of the avidin-A488 median FI, as measured in different donors, showed that the response increased with the strength of IL-33 stimulation (Fig 5, D) . Moreover, to test whether IL-33 potentiated degranulation also in ex vivo mast cells, we used mouse peritoneal cells sensitized with anti-DNP IgE. We observed that after stimulation with DNP-HSA, IL-33 pretreatment enhanced both the frequency of responder cells and their degranulation extent (see Fig E4, E and F). Taken together, our results indicate that IL-33 augments both the frequency of degranulating hMCs and the magnitude of individual hMC degranulation after FcεRI triggering.
To test whether IL-33 modulates individual mast cell function beyond degranulation, we analyzed production of the proinflammatory chemokines CCL4 and CXCL8 in IL-33-pretreated hMCs. hMCs pretreated or not with IL-33 for 1 hour were stimulated with anti-IgE antibodies for 3 hours to induce chemokine production. Cells were stained with avidin-A488; fixed, permeabilized, and stained for CCL4 or CXCL8; and analyzed by using flow cytometry. Flow cytometry dot plots showed a heterogeneity of the response, with cells exhibiting a large range of response intensities (Fig 6, A) . In the absence of Il-33 pretreatment, CCL4
1 frequency augmented according to the concentration of the anti-IgE antibody stimulus. IL-33 pretreatment by itself induced a low percentage of CCL4 1 or CXCL8 1 hMCs. Interestingly, IL-33 augmented both the frequency of CCL4 1 and CXCL8 1 cells and the extent of production of both chemokines at the single-cell level, mostly in conditions in which mast cells were stimulated by using a suboptimal concentration of anti-IgE antibodies (Fig 6, B-E) .
These results indicate that IL-33 induces the emergence of hMCs with a ''high-responder'' phenotype, both for degranulation and chemokine production, within an heterogeneous mast cell population.
DISCUSSION
Previously, we have shown that fluorescent avidin staining allows us to monitor spatiotemporal degranulation events in mast cells and that mast cells can polarize their secretion toward antibody-targeted cells. 40 We analyzed in-depth mast cell degranulation by investigating individual cell behavior within the whole population. Our study relies on fluorochrome-labeled avidin added in solution during mast cell stimulation. This probe immediately binds to the heparin-rich matrix exposed on the cell surface during the exocytosis process. Using this approach, we found a strong heterogeneity of mast cell biological responses after FcεRI aggregation. Individual mast cells provided all-or-none responses when triggered by anti-IgE antibodies, whereas they were activated in a graded fashion after pretreatment with increasing concentrations of IL-33.
It is established that IgE-mediated degranulation involves a phenomenon of compound exocytosis by which membranes of surrounding individual granules fuse with each other and with the plasma membrane forming intracellular degranulation chambers. 48, 49 Taken together with previous electron microscopy studies, 50 our confocal microscopy results suggest that granules can stay in those chambers or are extruded as pellets that can spread out in the extracellular space or remain attached to the cell surface. The advantage of our method over previous observations is that it allows measurement of the extent of degranulation in live cells and at the single-cell level by quantifying the exteriorized granule fraction that remains on the cell surface. It should be noted that this method can be used to monitor secretory lysosome exteriorization in other cell systems, such as melanoma cells. 51 Nongenetic cell-to-cell functional variability is an emerging concept that helps us better understand how individual cells behave after cell stimulation or drug treatment. 52, 53 Degranulation analysis by using flow cytometry makes conspicuous a strong heterogeneity of the mast cell response. This is in agreement with confocal microscopy results showing that fluorescent corona formation during the degranulation process is a progressive phenomenon plateauing at variable FI in individual cells. Interestingly, our approach also allowed us to measure degranulation and [Ca 21 ] i increase simultaneously in live cells, revealing that although mast cell degranulation magnitude is heterogeneous at the single-cell level, [Ca 21 ] i increase showed a noticeable homogeneity in virtually all cells. These results suggest that heterogeneity of degranulation responses in the mast cell population is downstream of early FcεRI-mediated signaling.
Another degree of heterogeneity of mast cell responses was observed when chemokine production was measured in parallel with degranulation. This analysis showed a large array of responses ranging from nonresponding cells to cells that provided a strong degranulation response without chemokine production and to cells that exhibited both degranulation and chemokine production. These results indicated that these mast cell functional outcomes are not necessary linked in individual cells and that multifunctional subpopulation can emerge after a given simulation. Such a functional heterogeneity has also been reported in human macrophage cell lines stimulated by LPS. 54, 55 It is tempting to speculate that a large array of individual mast cell behaviors might be instrumental for robust in vivo responses to different challenges. On the one hand, heterogeneous behaviors might allow avoidance of large synchronous responses of all tissue mast cells after antigen exposure, thus preventing possible deleterious reactions. On the other hand, they might be helpful to keep some mast cells in a nondegranulated status, ready to respond to repeated antigen stimulation or to other challenges by different antigens.
It is worthy to note that the hMC primary cell lines we generated from several donors were homogeneous in terms of CD117, FcεRI, tryptase, and chymase expression (see Fig E7 in this article's Online Repository at www.jacionline.org). These results, together with the observation that the whole hMC population increased [Ca 21 ] i and augmented phosphotyrosine levels in an homogeneous fashion in response to FcεRI triggering, rule out the possibility that the heterogeneity observed in functional responses might be due to heterogeneity in FcεRI triggering or granule content. Accordingly, it is well known that very low FcεRI expression allows efficient mast cell activation, 56 indicating that the level of FcεRI expression is not linked to the magnitude of functional responses. In other words, although all the cells were activated through FcεRI (as detected based on [Ca 21 ] i and phosphotyrosine measurements), a vast range of functional outcomes was observed.
We can hypothesize that important housekeeping cellular mechanisms or biochemical processes might interfere with cellular effector functions, such as degranulation or chemokine production. In this line heterogeneity in the mast cell degranulatory response was reported by Liu et al 57 by using an integrated microfluidic platform. The authors suggested that heterogeneity might stem from cell-to-cell variability in the copy number of the tyrosine kinase Lyn.
The concept of functional response heterogeneity is emerging in several cell models, including tumor cells, macrophages, and CD8 1 T lymphocytes. 29, 54, [58] [59] [60] In mast cells heterogeneity of the response was previously proposed by MacGlashan. 61 In our study we reinforce this notion by showing that homogeneous mast cell populations derived from blood progenitors still display different functional responses at the single-cell level. Because primary cell line heterogeneity might not always reflect an in vivo heterogeneity, we analyzed mouse peritoneal mast cell responses. Also, we observed an important functional heterogeneity in this ex vivo mast cell model.
Taken together, the above findings strongly suggest that the definition of functional signature in a single mast cell can provide some information that the study of their responses at the whole population level might not reveal. Indeed, in a bulk assay the responses are averaged out, and specific information from each cell can be lost.
Our approach also revealed that when the mast cell population was triggered by increasing concentrations of anti-IgE antibodies, the global Av.A488 gMFI increased according to the stimulus strength and paralleled b-hexosaminidase release in the culture medium. Interestingly, the global increase of Av.A488 fluorescence was the result of the recruitment of an increased number of mast cells to degranulate rather than the result of an increased extent of individual cell degranulation. This finding was made possible by a detailed analysis of the degranulated cells in which the distribution of Av.A488 FI was presented by using box-and-whisker plots. This analysis showed that increasing the stimulation strength through FcεRI augmented the probability to degranulate for individual cells on the one hand. On the other hand, the magnitude of degranulation (as detected by Av.A488 FI among Av.A488 1 cells) remained similar for all anti-IgE antibody concentrations tested, suggesting an all-ornone response. In this line studies based on different cellular models and stimulation systems reported that degranulation is an all-or-none response. [30] [31] [32] [33] Conversely, other studies reported that degranulation appears to be a graded process according to stimulation strength. 34, 35 The discrepancies between the abovementioned studies might stem from the use of different cellular models and stimuli or from the readouts used.
The methods used thus far to investigate degranulation were based on the measurement of cellular parameters indirectly related to granule exteriorization, such as Alcian blue staining loss, 30, 31 change in forward scatter, and loss of Acridine orange labeling or CD63 exposure. 34, 62 Those pioneering studies revealed the interest of single-cell analysis of degranulation. However, some methods (eg, CD63 exposure in basophils stimulated with anti-IgE) provided measurements that were not always correlated to the amount of mediators released, as discussed by MacGlashan. 34 Those results prompted us to analyze mast cell degranulation by using the CD63 exposure assay and the b-hexosaminidase release assay. Our results show that under our experimental conditions, CD63 exposure did not always follow b-hexosaminidase release, notably for supraoptimal stimulations (see Fig E8, A, in this article's Online Repository at www. jacionline.org). Indeed, the percentage of CD63
1 hMCs did not linearly correlate with the percentage of b-hexosaminidase release, which is in agreement with previous reports (see Fig  E8, B) . 34 In mast cells, contrary to the avidin-based assay, the CD63 exposure assay did not always reflect the process of mediator release and seems to not measure strictly the same phenomenon compared with the avidin-binding assay.
Mast cells are able to sense danger signals and notably express the ST2 receptor for the alarmin IL-33. Accordingly, the primary hMCs derived from peripheral blood progenitors used in this study expressed ST2 (see Fig E7) in agreement with Bandara et al. 63 Because IL-33 was shown to potentiate b-hexosaminidase release by RBL cells stimulated with IgE/antigen, 23 we analyzed the effect of IL-33 on hMCs at the single-cell level.
To accurately compare activation kinetics of cells pretreated with different concentrations of IL-33, we barcoded hMCs with a cell tracer. 64 To our knowledge, this is the first time that live cells were barcoded to analyze cellular responses by using time-lapse flow cytometry. As typically described for alarmins, IL-33 is expected to act swiftly on target cells. Thus we investigated the effect of IL-33 on mast cell biology after 1 hour of incubation. Time-lapse flow cytometric analysis revealed that IL-33 did not modify the kinetics of degranulation responses but dramatically increased the extent of those responses. Statistical analysis of Av.A488 FI of the degranulated cell population showed that pretreatment with IL-33 augmented not only the fraction of degranulated cells in response to FcεRI triggering but also the magnitude of individual cell degranulation. Those observations are in agreement with recent results by Sjoberg et al 21 showing that IL-33 causes increased mast cell b-hexosaminidase and serotonin secretion after antigen-induced degranulation in vivo, without increasing the number of tissue mast cells. Mast cell response enhancement by IL-33 is expected to be critical in allergic processes because this cytokine is produced by stressed epithelia on allergen contact. 8, 65 Because other cytokines, such as TSLP and IL-25, are also produced together with IL-33 in an allergic context, 8 we analyzed the effects of TSLP and IL-25 on mast cell degranulation. Our results showed no significant effect of TSLP or IL-25 on mast cell degranulation in our cellular model (see Fig E9 in this article' s Online Repository at www.jacionline. org).
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 2 We next investigated whether a delayed mast cell response distinct from degranulation might be also affected by IL-33. Our avidin-based method allowed us to simultaneously measure chemokine production and degranulation. CCL4 and CXCL8 production analysis using flow cytometry showed that IL-33 both potentiated the frequency of CCL4 1 and CXCL8 1 hMCs at the population level and augmented the amount of intracellular CCL4 and CXCL8 in individual cells. The signaling events underlying this phenomenon are poorly understood. Degranulation is mainly driven by rapid signaling events, such as intracellular calcium fluxes. In agreement with Andrade et al, 23 we did not find any effect of IL-33 on calcium fluxes elicited by FcεRI triggering, indicating that IL-33/ST2 signaling pathways, which remain to be elucidated, can prime mast cells to be more prone to degranulate and to exteriorize more granules.
All in all, these results suggest that mast cell degranulation is controlled through 2 mechanisms: one that functions similarly to a switch that induces mast cells to degranulate and a second that sets the magnitude of the degranulation. The IL-33/ST2 axis potentiates hMC responses induced by FcεRI engagement by increasing both mast cell degranulation frequency and degranulation magnitude. It is tempting to speculate that this potentiation mechanism exerted by IL-33 on mast cell degranulation and chemokine secretion might have a deep effect in conditions in which IgE-sensitized mast cells are primed with IL-33, such as in patients with asthma 18 or atopic dermatitis. 66 In such conditions allergen/IgE might stimulate mast cells and license degranulation, whereas IL-33 secretion might boost degranulation magnitude and exacerbate the clinical symptoms.
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Key messages
d Fluorescent avidin allows monitoring of mast cell degranulation at the single-cell and population levels by using time-lapse microscopy and flow cytometry. Intracellular chemokine staining hMCs (5 3 10 4 ) were pretreated with IL-33 for 1 hour in Tyrode buffer at 378C. Cells were next stimulated with increasing concentrations of anti-IgE antibodies for 3 hours. Cells were next stained with 5 mg/mL Av.A488 at 48C for 30 minutes, washed, fixed (2% paraformaldehyde), permeabilized (0.1% saponin in PBS containing 1% BSA, Sigma-Aldrich), and stained with anti-CCL4-PE-Cy7 or anti-CXCL8-PE mAbs for 45 minutes. Flow cytometric data were acquired on a MACSQuant Analyzer 10 (Miltenyi Biotec) and analyzed by using FlowJo software (TreeStar).
Mouse peritoneal cells
Peritoneal cells from 5 C57BL/6 mice were collected by means of peritoneal washing. Nonadherent cells were washed in Tyrode buffer, sensitized with 1 mg/mL anti-DNP IgE for 2 hours, washed in Tyrode buffer, pretreated or not with IL-33 for 1 hour, and stimulated with DNP-HSA for 30 minutes. Cells were then stained with av.A488, anti-mouse CD117-allophycocyanin (clone 2B8, BD Biosciences), and Fixable Viability Dye eFluor 506 (eBioscience) for 30 minutes at 48C and analyzed by using flow cytometry.
hMC stimulation by cell-bound antigens hMCs were sensitized or not with human IgE anti-CD20 (1 mg/mL; InvivoGen, San Diego, Calif) for 16 hours. The cells were then washed and distributed in 96-well flat-bottom plates at a density of 1 3 10 5 cells in 50 mL of Tyrode buffer and adapted to 378C for 20 minutes. hMCs were then treated with different ratios of JY cells (EBV-transformed lymphoblastoid cell line) in 50 mL of prewarmed Tyrode buffer for 60 minutes at 378C in a 5% CO 2 atmosphere. The cells were next stained with 5 mg/mL avidin-fluorescein isothiocyanate at 48C for 30 minutes and then proceeded to flow cytometric analysis. and-whisker plots from 1 representative experiment (Fig E3, C) or plotted as median FI from 6 independent experiments, and histograms represent means 6 SEMs (Fig E3, D) . E and F, Anti-CD20 IgE-sensitized hMCs were stimulated with increasing numbers of CD20 1 JY cells (B-EBV cell line) for 1 hour at 378C and then stained with Av.A488 and analyzed by using flow cytometry. Fig E3, E, against the B cell/hMC ratio. Each symbol represents an experiment. P values were determined by using the Mann-Whitney test (Fig E3, C) or Wilcoxon test (Fig E3, D and F) . ns, P > .05. *P < .05 and **P < .01. (Fig E4, C) or plotted as median FI from 5 independent experiments; histograms represent means 6 SEMs (Fig E4, D) . E, Frequency of Av.A488 1 pMCs. Data are shown as means 6 SEMs from 4 independent experiments. F, Av.A488 FI of the degranulated hMCs represented as median FI from 6 independent experiments; histograms represent means 6 SEMs. P values were determined by using the Mann-Whitney test (Fig E4, C) or paired t test (Fig E4, D-F) . ns, P > .05. *P < .05 and **P < .01. experiments. P values were determined by using the paired t test. C and D, Av.A488 FI of the degranulated hMCs represented as box-and-whisker plots from 2 representative experiment (Fig E6, C) or plotted as median FI from 6 independent experiments; histograms represent means 6 SEMs (Fig E6, D) . P values were determined by using the Mann-Whitney test (Fig E6, C) or Wilcoxon test (Fig E6, D) . ns, P > .05. *P < .05, **P < .01, ***P < .001, and ****P < .0001. . P values were determined by using the paired Student t test. Histograms represent means 6 SEMs from at least 4 independent experiments. ns, P > .05. *P < .05 and ****P < .0001.
